Ovarian most cancers sufferer Marianne says the ONX-0801 trial was her “solely choice”.
Your email address will not be published. Required fields are marked *
Sign me up for the newsletter!
The content is the property of the Roznama Urdu and without permission of the publisher will be considered copyright infringement..